{"id":58,"date":"2008-04-06T08:12:10","date_gmt":"2008-04-06T15:12:10","guid":{"rendered":"http:\/\/cchrstl.org\/wordpress\/?p=58"},"modified":"2024-07-14T05:43:53","modified_gmt":"2024-07-14T10:43:53","slug":"the-fda-issues-new-rules-on-drug-marketing","status":"publish","type":"post","link":"https:\/\/www.cchrstl.org\/wordpress\/2008\/04\/06\/the-fda-issues-new-rules-on-drug-marketing\/","title":{"rendered":"The FDA Issues New Rules on Drug Marketing"},"content":{"rendered":"
Your Comments are\u00c3\u201a\u00c2\u00a0Needed Now!<\/div>\n

\u00c3\u201a\u00c2\u00a0<\/p>\n

\u00c3\u201a\u00c2\u00a0\u00c3\u201a\u00c2\u00a0\u00c3\u201a\u00c2\u00a0\u00c3\u201a\u00c2\u00a0\u00c3\u201a\u00c2\u00a0 The FDA recently announced new rules on how drug companies can promote drugs to your doctor for purposes other than what they were approved for. You can probably think of your own examples, but what if your doctor was handed some new study showing that antidepressants were just great for treating the common cold.\u00c3\u201a\u00c2\u00a0While this example is admittedly farfetched, it isn’t out of the question.\u00c3\u201a\u00c2\u00a0This practice, known as off-label marketing, has been prohibited in many cases and for good reason.\u00c3\u201a\u00c2\u00a0Off-label marketing means that a company is promoting a drug for a different use or for a different population than it was intended for.\u00c3\u201a\u00c2\u00a0There could be all sorts of unknown risks.<\/font>\u00c3\u201a\u00c2\u00a0<\/p>\n

\u00c3\u201a\u00c2\u00a0\u00c3\u201a\u00c2\u00a0\u00c3\u201a\u00c2\u00a0\u00c3\u201a\u00c2\u00a0 While the use of drugs for unapproved purposes is certainly nothing new, allowing such marketing with little or no oversight is a move that puts us all at risk.\u00c3\u201a\u00c2\u00a0Luckily, these rules won’t go into effect immediately and are currently open for public comment.\u00c3\u201a\u00c2\u00a0So, the solution is simple:\u00c3\u201a\u00c2\u00a0Comment!\u00c3\u201a\u00c2\u00a0In fact, don’t just tell the agency what you think, send a copy of your comment to your Congressmen too.<\/font><\/p>\n

You can read the proposed rule here:<\/font><\/p>\n

www.fda.gov\/oc\/op\/goodreprint.html<\/font><\/a>.<\/font><\/p>\n

You can submit your comment here:<\/font><\/p>\n

Docket Number FDA-2008-D-0053<\/font><\/a><\/p>\n

To find your federal legislators, go to www.congress.org<\/a> and enter your zip code.<\/font><\/p>\n

Here are a few points that might help you formulate your comments:<\/font><\/p>\n

\u00c3\u201a\u00c2\u00a0\u00c3\u201a\u00c2\u00a0\u00c3\u201a\u00c2\u00a0\u00c3\u201a\u00c2\u00a0 While the FDA wants to protect the off-label marketing of drugs, states and other federal agencies have gone after numerous drug companies accused of off-label marketing schemes.\u00c3\u201a\u00c2\u00a0 Here are a few examples:
\n<\/font>\u00c3\u201a\u00c2\u00a0 <\/font><\/p>\n